Quickgene
AAA · Technical article

Amino Acid Analysis for Peptides and Proteins: Hydrolysis and Molar Ratios

By QuickgenePublished Approx. 7 min read

Abstract

Amino acid analysis (AAA) relies on hydrolysis recovery, calibration for each amino acid, and a clearly defined denominator. Octreotide acetate illustrates how to report relative molar ratios and check for threoninol. This article also explains how AAA complements peptide mapping, mass spectrometry, and chiral analysis. It also covers net peptide content determination and mass-balance checks.

Keywords: amino acid analysis, acid hydrolysis, AQC derivatization, amino acid molar ratio, octreotide acetate, net peptide content

1. What amino acid analysis can tell you

Amino acid analysis (AAA) measures the free amino acids released when a protein or peptide is hydrolyzed. Calibrating each amino acid allows its amount to be determined. If the molar amount of the original protein or peptide is also known reliably, the result can be expressed as moles of each residue per mole of the protein or peptide.

AAA can check the expected composition and provide an independent quantitative basis for assigning a reference value for protein content. Composition, sequence, and stereochemistry answer different questions. The report should specify which residues the hydrolysis procedure covers and how the denominator was determined.2

2. Hydrolysis, derivatization, and separation

Hydrolysis releases amino acid residues. Analytical options include precolumn derivatization, such as fluorescent AQC labeling, followed by reversed-phase liquid chromatography, or ion-exchange chromatography with postcolumn ninhydrin derivatization. The choice depends on the target residues, available instrumentation, and applicable product requirements.2

During method development, evaluate residue release and degradation during hydrolysis, the stability of derivative response, chromatographic resolution, and calibration. Better derivatization or separation cannot recover residues lost during hydrolysis.

Acid hydrolysis converts asparagine and glutamine to aspartic acid and glutamic acid, so conventional AAA reports Asx (Asn + Asp) and Glx (Gln + Glu). Distinguishing the amide forms requires a dedicated approach, such as chemical conversion before hydrolysis (for example, with BTI) or enzymatic hydrolysis.2,6

01
Hydrolysis
6 mol/L HCl · 110 °C · 24 h
Release residues
02
Derivatization
AQC
Control response
03
Separation
Calibrate each analyte

Scroll sideways to see the full figure →

Figure 1 Three stages of amino acid analysisWorkflow schematic. Comparable results depend on controlling hydrolysis recovery, derivative response, and chromatographic separation.

3. How hydrolysis time affects recovery

Hydrolysis with 6 mol/L hydrochloric acid at 110 °C for 24 hours can be a starting point for conventional acid hydrolysis. Some peptide bonds involving valine or isoleucine cleave slowly, while serine and threonine can degrade as hydrolysis continues. A time course can show when release plateaus for key residues. With sufficient data, extrapolation can help estimate the initial amount of a labile residue.2,6

Conventional hydrochloric acid hydrolysis is unsuitable for direct quantitation of tryptophan. If tryptophan is a target, evaluate alkaline hydrolysis or a suitable acid hydrolysis procedure that protects it. For cysteine and methionine, consider performic acid preoxidation as appropriate for the method objective, then measure cysteic acid and methionine sulfone, respectively. Record the hydrolysis conditions and how recovery was addressed.2,6

Slow release (Val / Ile) Labile (Ser / Thr) Time points 0%25%50%75%100%0 h12 h24 h36 h48 h60 h72 h Recovery Hydrolysis time Take plateau value ← Extrapolate to 0 h

Scroll sideways to see the full figure →

Figure 2 Using a hydrolysis time course to correct recoveryIllustrative curves, not measured data. Hydrolyze for several times (commonly 24, 48 and 72 h). For slowly released residues such as Val and Ile, take the plateau value; for labile residues such as Ser and Thr, extrapolate the time-course results back to 0 h to estimate the initial amount. Ser usually degrades faster than Thr. Set working conditions from time-course data for the target sample.

4. Choosing a denominator for the result

Absolute quantitation. Use suitable external or internal calibration to determine the molar amount of each residue, then divide by the independently determined molar amount of the protein or peptide. Report the residue-to-molecule molar ratio and document hydrolysis recovery and the basis for any correction.2

Normalization to anchor residues. Define a normalization unit from the calibrated amounts and expected residue counts of the selected anchor residues. Express each residue relative to that unit. The ratio depends on how reliably the anchor residues are recovered and quantified.1

Peak-area normalization. Response factors and hydrolysis losses differ by residue. An individual peak’s share of the total peak area cannot be interpreted directly as a mole fraction, mass fraction, or residue molar ratio.2

01
Absolute quantitation
Residue-to-molecule molar ratio
02
Anchor normalization
(Phe + Lys) ÷ 3
Ratio to the anchor unit
03
Peak-area normalization
Peak area fraction is not a molar ratio

Scroll sideways to see the full figure →

Figure 3 Absolute quantitation, anchor normalization, and peak-area normalizationIllustrative calculations. The divisor of 3 in the middle panel is the combined expected number of Phe and Lys residues in octreotide acetate.

5. Using AAA to determine net peptide content

A weighed peptide sample contains more than the peptide itself: water, counterions such as acetate or trifluoroacetate, and residual solvents also contribute to its mass. Net peptide content is the mass fraction of peptide in the sample, and AAA is a common way to measure it. Hydrolyze a weighed amount, quantify several residues that recover reliably, divide each measured molar amount by the expected residue count to obtain the molar amount of peptide, and convert it to mass using the molecular weight of the peptide.2,6

Net peptide content (%) = npeptide × Mfree base ÷ msample × 100, where npeptide is the mean of (measured moles of residue ÷ expected residue count) across the selected residues

Choose residues with stable recovery and reliable response. Ser, Thr, Cys, Met, Trp, and residues in slowly cleaved bonds are usually avoided. Results from the selected residues should agree with one another; poor agreement points to a hydrolysis or calibration problem. Report which residues were used, whether the molecular weight refers to the free base, and whether a recovery correction was applied.2,6

Net peptide content can be checked by mass balance against water content (Karl Fischer), counterion content (ion chromatography or HPLC), and residual solvents. A total close to 100% supports the result; a clear gap suggests an unaccounted component or a quantitation bias. Nitrogen determination (Kjeldahl or elemental analysis) is also used to estimate peptide content, but it cannot distinguish the target peptide from nitrogen-containing impurities such as related peptides or ammonium salts.

Net peptide content and HPLC purity answer different questions. Purity is a chromatographic peak-area fraction; net peptide content is a mass fraction. Their product is often used to approximate the amount of target peptide, for example when preparing solutions for bioassays or assigning a value to a reference material.

6. Composition testing for octreotide acetate

The Octreotide Acetate monograph in Part II of the 2025 Chinese Pharmacopoeia specifies preoxidation followed by acid hydrolysis. One normalization unit is one-third of the combined measured molar amounts of phenylalanine (Phe) and lysine (Lys). Octreotide has two Phe residues and one Lys residue. The monograph uses this unit to calculate relative residue ratios.1

Threonine (Thr) at position 6 contributes to the Thr ratio. Position 8 is L-threoninol, a terminal amino alcohol that the monograph checks separately by qualitative detection. Detecting threoninol provides evidence related to this terminus. This check alone cannot establish its position, integrity, or stereochemistry.1,5

ResidueExpected countLimit (relative ratio)Note
Cys21.7–2.3Measured as cysteic acid after performic acid oxidation
Thr10.8–1.2Position 6; threoninol at position 8 is not included
Phe21.8–2.2Anchor residue; position 1 is D-Phe, which achiral AAA does not distinguish
Lys10.9–1.1Anchor residue
Trp1Not determinedPosition 4 is D-Trp, destroyed by conventional acid hydrolysis
Threoninol1Qualitative detectionTerminal amino alcohol, checked separately
01
Preoxidation
30% H₂O₂ : HCOOH = 1 : 9
100 μL · 4 h
Ice-water bath; vacuum dry
02
Acid hydrolysis
100 μL · 6 mol/L HCl
110 °C · 24 h
Seal under nitrogen; dilute to 0.5 mg/mL
03
Suitable AAA method
For example AQC
Detect threoninol
04
Relative molar ratios
(Phe + Lys) ÷ 3
Phe: 2 · Lys: 1
Acceptance limits
Cys 1.7–2.3 · Thr 0.8–1.2 · Phe 1.8–2.2 · Lys 0.9–1.1

Scroll sideways to see the full figure →

Figure 4 Composition testing workflow for octreotide acetateWorkflow schematic. The preparation and limits reflect the Octreotide Acetate monograph in Part II of the 2025 Chinese Pharmacopoeia. Follow the current applicable product standard.

7. Validation, pharmacopoeial requirements, and data review

Assess selectivity, accuracy, precision, response, and reportable range against the intended use. Consider hydrolysis time, the interval from derivatization to injection, and sample and derivative stability. Spiking with free amino acids can check the measurement step. Use suitable process controls or reference materials to assess release and recovery during hydrolysis. An orthogonal method of known accuracy can also support the accuracy assessment.2,4

Part IV of the 2025 Chinese Pharmacopoeia includes General Chapter 9120. USP 〈1052〉 identifies its harmonization with corresponding chapters of the European and Japanese pharmacopoeias and marks the non-harmonized passages. Common hydrolysis procedures can serve as development starting points. The applicable product standard, regulatory commitments, and actual procedure determine suitability, use in batch release, and whether method verification, validation, or equivalence work is needed.1,2

Retain calibration curves, blanks, process control and system suitability results, and integration records for review. In the report, document response calibration, quantifiable residues, the basis for peak assignments, how anomalies were handled, and the normalization denominator.

8. How AAA complements peptide mapping, MS, and chiral analysis

Amino acid composition and intact molecular mass can support consistency with the expected residue composition and mass, respectively. Predict theoretical peptides from the known sequence and the cleavage rules used. Determine observed sequence coverage by matching peptides in a peptide map or LC–MS analysis. Conventional achiral AAA generally cannot distinguish D and L enantiomers. Use a suitable chiral method when stereochemistry must be assessed.3

For technical discussion. Follow the current applicable pharmacopoeial or approved standard for product tests and limits.

References

Pharmacopoeias, guidance, and structural references

  1. Chinese Pharmacopoeia, 2025 edition, Part IV, General Chapter 9120, and Part II, Octreotide Acetate monograph.
  2. USP 〈1052〉 Amino Acid Analysis. The corresponding European Pharmacopoeia chapter is Ph. Eur. 2.2.56.
  3. USP 〈1055〉 Peptide Mapping.
  4. ICH Q2(R2), Validation of Analytical Procedures.
  5. FDA structural information for octreotide acetate.
  6. Fountoulakis and Lahm, Hydrolysis and amino acid composition analysis of proteins.